HELIXOR Bio-Immunotherapy

HELIXOR Bio-Immunotherapy

Known for its anti-inflammatory and immunomodulating effects, HELIXOR Bio-Immunotherapy is a multi-beneficial therapy used to kill cancer cells and improve the overall quality of life for patients at Hope4Cancer.

An extract of European white-berried mistletoe, HELIXOR Bio-Immunotherapy contains both viscotoxins and lectins, two active compounds that directly affect cancer cells. Viscotoxins selectively damage the cell membrane and cytoskeleton of cancerous cells, while lectins inhibit ribosomes from producing new proteins and therefore stop the reproduction process of cancer cells, blocking tumor growth.

Due to its therapeutic properties and ability to regulate pain response, HELIXOR Bio-Immunotherapy can also be used as a supportive therapy for patients who have undergone traditional cancer treatments. For instance, helping to stimulate production of platelet and white or red blood cell counts that have gone low as a result of chemotherapy, as well as alleviating undesirable side effects (nausea, vomiting, anemia, etc.).

HELIXOR Bio-Immunotherapy is administered as an intravenous dose for ten days, after which patients switch to regular injections three times per week. As a result, patients will experience a slight fever response, with body temperatures increasing .5 to 1 degree Celsius. This response is a desirable effect, indicating immune stimulation. Body temperature and patient reactions are monitored throughout the entirety of the program.

References:

1. Oei SL, Thronicke A, Schad F. Mistletoe and Immunomodulation:
   Insights and Implications for Anticancer Therapies.
   Complement Alternat Med. 2019;2019:5893017. Published 2019 Apr
   17. doi:10.1155/2019/5893017
2. Lee, Y., Jung, I., & Lee, S. (2017). P2. 10
   Viscum Album (Helixor M) to Treat Malignant Pleural Effusion in
   Patients with Advanced Lung Cancer.
   Oncology, 12(11), S2161.
3. Yang P, Jiang Y, Pan Y, et al. Mistletoe extract Fraxini inhibits the
   proliferation of liver cancer by down-regulating c-Myc
   expression. Sci Rep. 2019;9(1):6428. Published 2019 Apr 23.
   doi:10.1038/s41598-019-41444-2
4. A Systematic Review and Meta-Analysis on the Survival of Cancer
   Patients Treated with a Fermented Viscum album L. Extract
   (Iscador): An Update of Findings
   Ostermann T.a · Appelbaum S.a · PoierD.b · Boehm
   · BüssingA.b
   Complement Med Res
   https://doi.org/10.1159/000505202